These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19337819)

  • 41. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
    Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
    Coriat R; Mir O; Camps S; Ropert S; Billemont B; Leconte M; Larousserie F; Anract P; Alexandre J; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Soft tissue sarcoma: postoperative chemotherapy].
    Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in chemotherapy for patients with extremity soft tissue sarcoma.
    Eilber FC; Tap WD; Nelson SD; Eckardt JJ; Eilber FR
    Orthop Clin North Am; 2006 Jan; 37(1):15-22. PubMed ID: 16311108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
    J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
    Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuously improving ifosfamide/mesna: a winning combination.
    Anderson P
    Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648
    [No Abstract]   [Full Text] [Related]  

  • 49. The role of ifosfamide in the treatment of sarcomas.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retroperitoneal synovial sarcoma.
    Domşa I; Crişan D; Olinici CD
    Rom J Morphol Embryol; 2006; 47(2):187-91. PubMed ID: 17106529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
    Antman KH; Elias A; Ryan L
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):68-73. PubMed ID: 2110386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals.
    Penel N; Ryckewaert T; Pannier D
    Cancer; 2020 Oct; 126(20):4614-4615. PubMed ID: 32767671
    [No Abstract]   [Full Text] [Related]  

  • 53. Reply to Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals.
    D'Ambrosio L; Litière S; Stacchiotti S; Gronchi A
    Cancer; 2020 Oct; 126(20):4615-4616. PubMed ID: 32767667
    [No Abstract]   [Full Text] [Related]  

  • 54. Langerhans cell sarcoma: a systematic review.
    Howard JE; Dwivedi RC; Masterson L; Jani P
    Cancer Treat Rev; 2015 Apr; 41(4):320-31. PubMed ID: 25805533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rare case of Langerhans cell sarcoma with cutaneous manifestation arising on the inguinal region.
    Jimura N; Matsushita S; Baba N; Kubo H; Takeda K; Fukushige T; Fujii K; Kanekura T
    J Dermatol; 2014 Dec; 41(12):1127-8. PubMed ID: 25387842
    [No Abstract]   [Full Text] [Related]  

  • 56. Primary cutaneous langerhans cell sarcoma: a report of four cases and review of the literature.
    Sagransky MJ; Deng AC; Magro CM
    Am J Dermatopathol; 2013 Apr; 35(2):196-204. PubMed ID: 23051626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Langerhans cell sarcoma: Response to radiotherapy.
    Lucas A; Barca EG; Servitje O; Abenoza L; González MN; Macià M; Lozano A
    Rep Pract Oncol Radiother; 2010; 15(4):107-9. PubMed ID: 24376934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy for Langerhans cell sarcoma.
    Ohara G; Funayama Y; Satoh H; Uchida K
    J Orthop Sci; 2009 Mar; 14(2):242-3. PubMed ID: 19337819
    [No Abstract]   [Full Text] [Related]  

  • 59. Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen.
    Uchida K; Kobayashi S; Inukai T; Noriki S; Imamura Y; Nakajima H; Yayama T; Orwotho N; Baba H
    J Orthop Sci; 2008 Jan; 13(1):89-93. PubMed ID: 18274862
    [No Abstract]   [Full Text] [Related]  

  • 60. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
    Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
    J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.